Ellis Investment Partners LLC Purchases Shares of 157,642 Colgate-Palmolive (CL)

Share on StockTwits

Ellis Investment Partners LLC purchased a new stake in Colgate-Palmolive (NYSE:CL) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 157,642 shares of the company’s stock, valued at approximately $157,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CL. Norges Bank acquired a new position in Colgate-Palmolive in the 4th quarter valued at $488,436,000. BlackRock Inc. increased its stake in Colgate-Palmolive by 13.5% in the 4th quarter. BlackRock Inc. now owns 60,648,605 shares of the company’s stock valued at $3,609,804,000 after buying an additional 7,236,342 shares during the period. Oregon Public Employees Retirement Fund increased its stake in Colgate-Palmolive by 5,779.5% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,625,533 shares of the company’s stock valued at $95,000 after buying an additional 5,529,852 shares during the period. Ceredex Value Advisors LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at $71,576,000. Finally, Los Angeles Capital Management & Equity Research Inc. increased its stake in Colgate-Palmolive by 405.4% in the 4th quarter. Los Angeles Capital Management & Equity Research Inc. now owns 1,283,928 shares of the company’s stock valued at $76,419,000 after buying an additional 1,029,873 shares during the period. 76.04% of the stock is currently owned by institutional investors.

In related news, insider Jennifer Daniels sold 3,498 shares of the business’s stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.39, for a total value of $232,232.22. Following the sale, the insider now directly owns 38,824 shares in the company, valued at approximately $2,577,525.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Ian M. Cook sold 22,634 shares of the business’s stock in a transaction dated Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the sale, the chief executive officer now owns 1,162,793 shares in the company, valued at $77,104,803.83. The disclosure for this sale can be found here. Insiders sold a total of 116,920 shares of company stock worth $7,917,830 over the last quarter. Insiders own 1.14% of the company’s stock.

NYSE:CL opened at $71.82 on Friday. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.74 and a current ratio of 1.07. Colgate-Palmolive has a fifty-two week low of $57.41 and a fifty-two week high of $72.85. The firm has a market cap of $62.49 billion, a PE ratio of 24.18, a P/E/G ratio of 4.77 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The business had revenue of $3.88 billion for the quarter, compared to analysts’ expectations of $3.86 billion. During the same period in the prior year, the company posted $0.74 EPS. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive will post 2.83 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Wednesday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.39%. Colgate-Palmolive’s dividend payout ratio is 57.91%.

Several equities analysts have issued reports on CL shares. Goldman Sachs Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research note on Tuesday, January 8th. Zacks Investment Research raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Thursday, January 10th. Evercore ISI began coverage on shares of Colgate-Palmolive in a research note on Thursday, January 10th. They set an “outperform” rating and a $70.00 price target on the stock. Wells Fargo & Co reaffirmed a “hold” rating and set a $57.00 price target on shares of Colgate-Palmolive in a research note on Friday, January 25th. Finally, Morgan Stanley set a $62.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Tuesday, January 29th. One research analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and an average target price of $69.81.

TRADEMARK VIOLATION WARNING: “Ellis Investment Partners LLC Purchases Shares of 157,642 Colgate-Palmolive (CL)” was first reported by Week Herald and is owned by of Week Herald. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://weekherald.com/2019/05/03/ellis-investment-partners-llc-purchases-shares-of-157642-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Article: How do candlesticks reflect price movement?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.